Paul Magrez
Nessuna posizione attualmente
Profilo
Paul Magrez is the founder of Dr. Magrez BVBA, founded in 2011.
He was the Chief Executive Officer of Theradiag SA and Laboratoire Cerba SA. He was also the Executive Director-Business Operations at GSK Plc from 1997 to 2001.
He served as the Chief Executive & Operating Officer at Fujirebio Europe NV from 2001 to 2007.
He was a Manager-Research & Development at UCB Pharma SA (Belgium) from 1988 to 1992.
He was an Independent Non-Executive Director at Bone Therapeutics SA from 2015 to 2018.
He was a Partner at Fund+ from 2015 to 2018.
He was the Chairman & Chief Executive Officer of BARC SCS in 2011.
Precedenti posizioni note di Paul Magrez
| Società | Posizione | Fine |
|---|---|---|
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investitore di Private Equity | 30/06/2018 |
| BIOSENIC SA | Direttore/Membro del Consiglio | 14/06/2018 |
BARC SCS
 BARC SCS Miscellaneous Commercial ServicesCommercial Services BARC NV provides central laboratory services. It specializes in testing wide range of fields including virology, microbiology, clinical pathology, and genetics. The firm offers biobanking, cerba specimen, custom test development, data management, investigator support, project management, and logistics. The company is headquartered in Ghent, Belgium. | Amministratore Delegato | 01/01/2011 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Amministratore Delegato | 01/01/2007 |
| GSK PLC | Corporate Officer/Principal | 01/01/2001 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 8 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
BARC SCS
BARC SCS Miscellaneous Commercial ServicesCommercial Services BARC NV provides central laboratory services. It specializes in testing wide range of fields including virology, microbiology, clinical pathology, and genetics. The firm offers biobanking, cerba specimen, custom test development, data management, investigator support, project management, and logistics. The company is headquartered in Ghent, Belgium. | Commercial Services |
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Laboratoire Cerba SA
 Laboratoire Cerba SA Miscellaneous Commercial ServicesCommercial Services Laboratoire Cerba SA provides medical research services. It conducts tests in the fields of virology, autoimmune disease, allergy, endocrinology, oncology, toxicology and molecular genomics. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. | Commercial Services |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
| Paul Magrez BV | |
Fund+
Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Finance |
- Borsa valori
- Insiders
- Paul Magrez
